Evidence map›Paper›PMID 29594931›Full record

ArticleEJNMMI research2018

Validation of [

R Iqbal, G M Kramer, V Frings, E F Smit, O S Hoekstra, R Boellaard, QuIC-ConCePT Consortium

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in EJNMMI research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. 3'-deoxy-3'-EJNMMI research · 2025
    Article
  2. Review
  3. Predictive value of 3'-deoxy-3'-Journal for immunotherapy of cancer · 2021
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

R IqbalDepartment of Radiology & Nuclear Medicine, VU University Medical Center, PO Box 7057, 1007, MB, Amsterdam, The Netherlands. r.iqbal@vumc.nl.
G M KramerDepartment of Radiology & Nuclear Medicine, VU University Medical Center, PO Box 7057, 1007, MB, Amsterdam, The Netherlands.
V FringsDepartment of Radiology & Nuclear Medicine, VU University Medical Center, PO Box 7057, 1007, MB, Amsterdam, The Netherlands.
E F SmitDepartment of Pulmonology, VU University Medical Center, Amsterdam, The Netherlands.
O S HoekstraDepartment of Radiology & Nuclear Medicine, VU University Medical Center, PO Box 7057, 1007, MB, Amsterdam, The Netherlands.
R BoellaardDepartment of Radiology & Nuclear Medicine, VU University Medical Center, PO Box 7057, 1007, MB, Amsterdam, The Netherlands.
QuIC-ConCePT Consortium
Amsterdam UMC Location VUmc · NL

Funding

Innovative Medicines Initiative Joint Undertaking 115151
6 · The paper itself

Abstract

background3'-Deoxy-3'-[

resultsA total of 17 perfusion and 18 [

conclusionThe present study suggests that [

trial registrationNederlands Trial Register (NTR), NTR3557 . Registered 2 August 2012.

Indexed as

[18F]FLTNon-small cell lung cancer (NSCLC)PerfusionPositron emission tomography (PET)Tyrosine kinase inhibitors (TKIs)

Identifiers

PMID29594931
PMCPMC5874225
OpenAlexW2795681252

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.